Skip to main content
Log in

Head and neck cancers: reporting indications and results of hadrontherapy of a dual beam facility

  • Original Paper
  • Published:
Health and Technology Aims and scope Submit manuscript

Abstract

Purpose

To review experience and indications for head and neck (HN) tumors at our center in relation to the published literature.

Methods

HN cancer patients treated at our center either with protons (PT) or carbon ions (CIRT) were extracted from our institutional retrospective and longitudinal Registry (NCT05203250 REGAL), including all the patients treated since the beginning of our clinical activity. A literature search was conducted with selection of most representative published studies for adenoid cystic carcinoma (ACC), mucosal melanoma (MM), sinonasal cancers (SNCs) and reirradiations.

Results

Since the beginning of the clinical activity in 2011, 1311 HN tumors have been treated a tour center. Majority of treated patients were ACC (52%), non-ACC salivary gland tumors (18%), paranasal sinuses tumors (9%), MM (7%), and reirradiation of recurrent tumors after previous RT (14%). Oncological outcome in terms of safety and efficacy has been published on the series of 184 ACC and 40 MM, both treated with CIRT in the years 2013–2020. Reviewed reirradiation published series included a cohort of 52 recurrent salivary gland tumors retreated with CIRT from 2013 to 2016, and the experience of 2013–2020 of retreatment of 15 SNCs (13 with CIRT and 2 with PT).

Conclusion

HN tumors are major indications for particle treatment around the world and at our center. Particle treatment might be personalized for each patient, with CIRT indicated for radioresistant tumors such as ACC and MM. Data on oncologic outcomes of CIRT at our center are consistent with published series.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Data availability statement

Requests to the corresponding author will follow internal procedures according to the center ethic and privacy policy.

Reference

  1. Orlandi E, Barcellini A, Vischioni B, Fiore MR, Vitolo V, Iannalfi A, Bonora M, Chalaszczyk A, Ingargiola R, Riva G, Ronchi S, Valvo F, Fossati P, Ciocca M, Mirandola A, Molinelli S, Pella A, Baroni G, Pullia MG, Facoetti A, Orecchia R, Licitra L, Vago G, Rossi S. The Role of Carbon Ion Therapy in the Changing Oncology Landscape-A Narrative Review of the Literature and the Decade of Carbon Ion Experience at the Italian National Center for Oncological Hadrontherapy. Cancers (Basel). 2023;15(20):5068. https://doi.org/10.3390/cancers15205068.

    Article  CAS  PubMed  Google Scholar 

  2. Tinganelli W, Durante M. Carbon Ion Radiobiology. Cancers (Basel). 2020;12(10):3022. https://doi.org/10.3390/cancers12103022.

    Article  CAS  PubMed  Google Scholar 

  3. Loap P, Vischioni B, Bonora M, Ingargiola R, Ronchi S, Vitolo V, Barcellini A, Goanta L, De Marzi L, Dendale R, Pacelli R, Locati L, Calugaru V, Mammar H, Cavalieri S, Kirova Y, Orlandi E. Biological Rationale and Clinical Evidence of Carbon Ion Radiation Therapy for Adenoid Cystic Carcinoma: A Narrative Review. Front Oncol. 2021;30(11):789079. https://doi.org/10.3389/fonc.2021.789079.

    Article  CAS  Google Scholar 

  4. Barcellini A, Vitolo V, Facoetti A, Fossati P, Preda L, Fiore MR, Vischioni B, Iannalfi A, Bonora M, Ronchi S, D’Ippolito E, Petrucci R, Viselner G, Ciocca M, Valvo F, Orecchia R. Feasibility of Carbon Ion Radiotherapy in the Treatment of Gynecological Melanoma. In Vivo. 2009;33(2):473–6. https://doi.org/10.21873/invivo.11497.

    Article  CAS  Google Scholar 

  5. Jensen AD, Poulakis M, Nikoghosyan AV, Welzel T, Uhl M, Federspil PA, Freier K, Krauss J, Höss A, Haberer T, Jäkel O, Münter MW, Schulz-Ertner D, Huber PE, Debus J. High-LET radiotherapy for adenoid cystic carcinoma of the head and neck: 15 years’ experience with raster-scanned carbon ion therapy. Radiother Oncol. 2016;118(2):272–80. https://doi.org/10.1016/j.radonc.2015.05.010.

    Article  PubMed  Google Scholar 

  6. Locati LD, Ferrarotto R, Licitra L, Benazzo M, Preda L, Farina D, Gatta G, Lombardi D, Nicolai P, Vander Poorten V, Chua MLK, Vischioni B, Sanguineti G, Morbini P, Fonseca I, Sozzi D, Merlotti A, Orlandi E. Current management and future challenges in salivary glands cancer. Front Oncol. 2023;19(13):1264287. https://doi.org/10.3389/fonc.2023.1264287.

    Article  CAS  Google Scholar 

  7. Orlandi E, Iacovelli NA, Bonora M, Cavallo A, Fossati P. Salivary Gland: Photon beam and particle radiotherapy: Present and future. Oral Oncol. 2016;60:146–56. https://doi.org/10.1016/j.oraloncology.2016.06.019.

    Article  PubMed  Google Scholar 

  8. Mendenhall WM, Morris CG, Amdur RJ, Werning JW, Hinerman RW, Villaret DB. Radiotherapy alone or combined with surgery for adenoid cystic carcinoma of the head and neck. Head Neck. 2004;26(2):154–62. https://doi.org/10.1002/hed.10380.

    Article  PubMed  Google Scholar 

  9. Laramore GE, Krall JM, Griffin TW, Duncan W, Richter MP, Saroja KR, Maor MH, Davis LW. Neutron versus photon irradiation for unresectable salivary gland tumors: final report of an RTOG-MRC randomized clinical trial. Radiation Therapy Oncology Group, Medical Research Council. Int J Radiat Oncol Biol Phys. 1993;27(2):235–40. https://doi.org/10.1016/0360-3016(93)90233-l.

    Article  CAS  PubMed  Google Scholar 

  10. Sulaiman NS, Demizu Y, Koto M, Saitoh JI, Suefuji H, Tsuji H, Ohno T, Shioyama Y, Okimoto T, Daimon T, Nemoto K, Nakano T, Kamada T, Japan Carbon-Ion Radiation Oncology Study Group. Multicenter Study of Carbon-Ion Radiation Therapy for Adenoid Cystic Carcinoma of the Head and Neck: Subanalysis of the Japan Carbon-Ion Radiation Oncology Study Group (J-CROS) Study (1402 HN). Int J Radiat Oncol Biol Phys. 2018;100(3):639–46. https://doi.org/10.1016/j.ijrobp.2017.11.010.

    Article  Google Scholar 

  11. Iannalfi A, D’Ippolito E, Riva G, Molinelli S, Gandini S, Viselner G, Fiore MR, Vischioni B, Vitolo V, Bonora M, Ronchi S, Petrucci R, Barcellini A, Mirandola A, Russo S, Vai A, Mastella E, Magro G, Maestri D, Ciocca M, Preda L, Valvo F, Orecchia R. Proton and carbon ion radiotherapy in skull base chordomas: a prospective study based on a dual particle and a patient-customized treatment strategy. Neuro Oncol. 2020;22(9):1348–58. https://doi.org/10.1093/neuonc/noaa067. Erratum. In: Neuro Oncol. 2022 Aug 1;24(8):1402–1403.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Molinelli S, Bonora M, Magro G, Casale S, Dale JE, Fossati P, Hasegawa A, Mirandola A, Ronchi S, Russo S, Preda L, Valvo F, Orecchia R, Ciocca M, Vischioni B. RBE-weighted dose in carbon ion therapy for ACC patients: Impact of the RBE model translation on treatment outcomes. Radiother Oncol. 2019;141:227–33. https://doi.org/10.1016/j.radonc.2019.08.022.

    Article  CAS  PubMed  Google Scholar 

  13. Vischioni B, Bonora M, Ronchi S, Ingargiola R, Camarda AM, Molinelli S, Imparato S, Fiorino F, Rancati T, Ciocca M, Orlandi E. OC-0110 Head and neck adenoid cystic carcinoma treated with raster scanning carbon ion radiotherapy at CNAO. Radiother Oncol. 2023;182:S70–1. https://doi.org/10.1016/S0167-8140(23)08524-9.

    Article  Google Scholar 

  14. Wada H, Nemoto K, Ogawa Y, Hareyama M, Yoshida H, Takamura A, Ohmori K, Hamamoto Y, Sugita T, Saitoh M, Yamada S. A multi-institutional retrospective analysis of external radiotherapy for mucosal melanoma of the head and neck in Northern Japan. Int J Radiat Oncol Biol Phys. 2004;59(2):495–500. https://doi.org/10.1016/j.ijrobp.2003.11.013.

    Article  PubMed  Google Scholar 

  15. Mizoe JE, Hasegawa A, Jingu K, Takagi R, Bessyo H, Morikawa T, Tonoki M, Tsuji H, Kamada T, Tsujii H, Okamoto Y, Organizing Committee for the Working Group for Head Neck Cancer. Results of carbon ion radiotherapy for head and neck cancer. Radiother Oncol. 2012;103(1):32–7. https://doi.org/10.1016/j.radonc.2011.12.013.

    Article  Google Scholar 

  16. Yanagi T, Mizoe JE, Hasegawa A, Takagi R, Bessho H, Onda T, Kamada T, Okamoto Y, Tsujii H. Mucosal malignant melanoma of the head and neck treated by carbon ion radiotherapy. Int J Radiat Oncol Biol Phys. 2009;74(1):15–20. https://doi.org/10.1016/j.ijrobp.2008.07.056.

    Article  PubMed  Google Scholar 

  17. Koto M, Demizu Y, Saitoh JI, Suefuji H, Tsuji H, Okimoto T, Ohno T, Shioyama Y, Takagi R, Nemoto K, Nakano T, Kamada T, Japan Carbon-Ion Radiation Oncology Study Group. Multicenter Study of Carbon-Ion Radiation Therapy for Mucosal Melanoma of the Head and Neck: Subanalysis of the Japan Carbon-Ion Radiation Oncology Study Group (J-CROS) Study (1402 HN). Int J Radiat Oncol Biol Phys. 2017;97(5):1054–60. https://doi.org/10.1016/j.ijrobp.2016.12.028.

    Article  Google Scholar 

  18. Ronchi S, Cicchetti A, Bonora M, Ingargiola R, Camarda AM, Russo S, Imparato S, Castelnuovo P, Pasquini E, Nicolai P, Ansarin M, Del Vecchio M, Benazzo M, Orlandi E, Vischioni B. Curative carbon ion radiotherapy in a head and neck mucosal melanoma series: Facing the future within multidisciplinarity. Radiother Oncol. 2023;11(190):110003. https://doi.org/10.1016/j.radonc.2023.110003.

    Article  CAS  Google Scholar 

  19. Hanaoka Y, Tanemura A, Takafuji M, Kiyohara E, Arase N, Suzuki O, Isohashi F, Ogawa K, Fujimoto M. Local and disease control for nasal melanoma treated with radiation and concomitant anti-programmed death 1 antibody. J Dermatol. 2020;47(4):423–5. https://doi.org/10.1111/1346-8138.15256.

    Article  CAS  PubMed  Google Scholar 

  20. Musha A, Kubo N, Kawamura H, Okano N, Sato H, Okada K, Tomizawa K, Ota N, Adachi A, Shino M, Nikkuni O, Ida S, Shirai K, Saitoh JI, Yokoo S, Chikamatsu K, Ohno T. Efficacy of immune checkpoint inhibitor treatment for head and neck mucosal melanoma recurrence in patients treated with carbon-ion radiotherapy. Cancer Rep (Hoboken). 2023;6(7):e1825. https://doi.org/10.1002/cnr2.1825.

    Article  CAS  PubMed  Google Scholar 

  21. Cavalieri S, Ronchi S, Barcellini A, Bonora M, Vischioni B, Vitolo V, Villa R, Del Vecchio M, Licitra L, Orlandi E. Toxicity of carbon ion radiotherapy and immune checkpoint inhibitors in advanced melanoma. Radiother Oncol. 2021;164:1–5. https://doi.org/10.1016/j.radonc.2021.08.021.

    Article  CAS  PubMed  Google Scholar 

  22. Llorente JL, López F, Suárez C, Hermsen MA. Sinonasal carcinoma: clinical, pathological, genetic and therapeutic advances. Nat Rev Clin Oncol. 2014;11(8):460–72. https://doi.org/10.1038/nrclinonc.2014.97.

    Article  PubMed  Google Scholar 

  23. Orlandi E, Cavalieri S, Granata R, Nicolai P, Castelnuovo P, Piazza C, Schreiber A, Turri-Zanoni M, Quattrone P, Miceli R, Infante G, Sessa F, Facco C, Calareso G, Iacovelli NA, Mattavelli D, Paderno A, Resteghini C, Locati LD, Licitra L, Bossi P. Locally advanced epithelial sinonasal tumors: The impact of multimodal approach. Laryngoscope. 2020;130(4):857–65. https://doi.org/10.1002/lary.28202.

    Article  PubMed  Google Scholar 

  24. Patel SH, Wang Z, Wong WW, Murad MH, Buckey CR, Mohammed K, Alahdab F, Altayar O, Nabhan M, Schild SE, Foote RL. Charged particle therapy versus photon therapy for paranasal sinus and nasal cavity malignant diseases: a systematic review and meta-analysis. Lancet Oncol. 2014;15(9):1027–38. https://doi.org/10.1016/S1470-2045(14)70268-2.

    Article  CAS  PubMed  Google Scholar 

  25. Ramaekers BL, Pijls-Johannesma M, Joore MA, van den Ende P, Langendijk JA, Lambin P, Kessels AG, Grutters JP. Systematic review and meta-analysis of radiotherapy in various head and neck cancers: comparing photons, carbon-ions and protons. Cancer Treat Rev. 2011;37(3):185–201. https://doi.org/10.1016/j.ctrv.2010.08.004.

    Article  CAS  PubMed  Google Scholar 

  26. Zhang W, Hu W, Hu J, Gao J, Yang J, Kong L, Lu JJ. Carbon ion radiation therapy for sinonasal malignancies: Promising results from 2282 cases from the real world. Cancer Sci. 2020;111:4465–79.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Resteghini C, Castelnuovo P, Nicolai P, Orlandi E, Bossi P, Vischioni B, Schreiber A, Gambazza S, Iacovelli NA, Battaglia P, Guzzo M, Turri-Zanoni M, Mattavelli D, Facchinetti N, Calareso G, Ravanelli M, Facco C, Tartaro T, Licitra L. The SINTART 1 study: A phase II non-randomised controlled trial of induction chemotherapy, surgery, photon-, proton- and carbon ion-based radiotherapy integration in patients with locally advanced resectable sinonasal tumours. Eur J Cancer. 2023;187:185–94. https://doi.org/10.1016/j.ejca.2023.03.033.

    Article  CAS  PubMed  Google Scholar 

  28. Bossi P, Orlandi E, Resteghini C, Vischioni B, Nicolai P, Castelnuovo P, Gambazza S, Locati LD, Turri-Zanoni M, Ferrari M, Facchinetti N, Iacovelli NA, Calareso G, Quattrone P, Cavallo A, Tuzi A, Licitra L. The SINTART 2 Study. A phase II non-randomised controlled trial of induction chemotherapy, photon-, proton- and carbon-ion-based radiotherapy integration in patients with locally advanced unresectable sinonasal tumours. Eur J Cancer. 2023;187:134–43. https://doi.org/10.1016/j.ejca.2023.03.034.

    Article  CAS  PubMed  Google Scholar 

  29. Mirandola A, Russo S, Bonora M, Vischioni B, Camarda AM, Ingargiola R, Molinelli S, Ronchi S, Rossi E, Vai A, Iacovelli NA, Thariat J, Ciocca M, Orlandi E. A Patient Selection Approach Based on NTCP Models and DVH Parameters for Definitive Proton Therapy in Locally Advanced Sinonasal Cancer Patients. Cancers (Basel). 2022;14(11):2678. https://doi.org/10.3390/cancers14112678.

    Article  CAS  PubMed  Google Scholar 

  30. Takiar V, Garden AS, Ma D, Morrison WH, Edson M, Zafereo ME, Gunn GB, Fuller CD, Beadle B, Frank SJ, William WN Jr, Kies M, El-Naggar AK, Weber R, Rosenthal DI, Phan J. Reirradiation of Head and Neck Cancers With Intensity Modulated Radiation Therapy: Outcomes and Analyses. Int J Radiat Oncol Biol Phys. 2016;95(4):1117–31. https://doi.org/10.1016/j.ijrobp.2016.03.015.

    Article  PubMed  Google Scholar 

  31. Bhattacharyya T, Koto M, Windisch P, Ikawa H, Hagiwara Y, Tsuji H, Adeberg S. Emerging Role of Carbon Ion Radiotherapy in Reirradiation of Recurrent Head and Neck Cancers: What Have We Achieved So Far? Front Oncol. 2022;23(12):888446. https://doi.org/10.3389/fonc.2022.888446.

    Article  CAS  Google Scholar 

  32. Blanchard P, Gunn GB, Lin A, Foote RL, Lee NY, Frank SJ. Proton Therapy for Head and Neck Cancers. Semin Radiat Oncol. 2018;28(1):53–63. https://doi.org/10.1016/j.semradonc.2017.08.004.

    Article  PubMed  Google Scholar 

  33. Held T, Windisch P, Akbaba S, Lang K, El Shafie R, Bernhardt D, Plinkert P, Kargus S, Rieken S, Herfarth K, Debus J, Adeberg S. Carbon Ion Reirradiation for Recurrent Head and Neck Cancer: A Single-Institutional Experience. Int J Radiat Oncol Biol Phys. 2019;105(4):803–11. https://doi.org/10.1016/j.ijrobp.2019.07.021.

    Article  CAS  PubMed  Google Scholar 

  34. Vischioni B, Dhanireddy B, Severo C, Bonora M, Ronchi S, Vitolo V, Fiore MR, D’Ippolito E, Petrucci R, Barcellini A, Ciurlia E, Iannalfi A, Hasegawa A, Molinelli S, Mirandola A, Valvo F, Orecchia R. Reirradiation of salivary gland tumors with carbon ion radiotherapy at CNAO. Radiother Oncol. 2020;145:172–7. https://doi.org/10.1016/j.radonc.2020.01.004.

    Article  CAS  PubMed  Google Scholar 

  35. Hayashi K, Koto M, Ikawa H, Hagiwara Y, Tsuji H, Ogawa K, Kamada T. Feasibility of Re-irradiation using carbon ions for recurrent head and neck malignancies after carbon-ion radiotherapy. Radiother Oncol. 2019;136:148–53. https://doi.org/10.1016/j.radonc.2019.04.007.

    Article  CAS  PubMed  Google Scholar 

  36. Gao J, Hu J, Guan X, Yang J, Hu W, Kong L, Lu JJ. Salvage Carbon-Ion Radiation Therapy For Locoregionally Recurrent Head and Neck Malignancies. Sci Rep. 2019;9(1):4259. https://doi.org/10.1038/s41598-019-39241-y.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Vischioni B, Ingargiola R, Bonora M, Ronchi S, Camarda AM, Russo S, Rossi E, Magro G, Mirandola A, Orlandi E. Particle Reirradiation of Malignant Epithelial and Neuroectodermal Sinonasal Tumors: A Case Series from CNAO. J Clin Med. 2023;12(7):2624. https://doi.org/10.3390/jcm12072624.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Funding

This work has been partly founded by the European Union’s Horizon 2020 Research and Innovation program under grant agreement No 101008548 (HITRIplus).

Author information

Authors and Affiliations

Authors

Contributions

Conceptualization: B.V. and E.O.; writing-original draft preparation: B.V.; writing-review and editing: B.V., M.B., S.R. (Sara Ronchi), R.I., A.M.C., S.L., E.R., M.P., S.R. (Stefania Russo), A.M., S.I. and S.M.

Corresponding author

Correspondence to Barbara Vischioni.

Ethics declarations

Ethical approval

No ethical approval was required for this article.

Consent to participate

No consent to participate was required for this article.

Consent to publish

No consent to publish was required for this article.

Competing interest

The author(s) have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Hadrontherapy and BNCT: Current Status and Future Trends

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Vischioni, B., Bonora, M., Ronchi, S. et al. Head and neck cancers: reporting indications and results of hadrontherapy of a dual beam facility. Health Technol. (2024). https://doi.org/10.1007/s12553-024-00843-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12553-024-00843-w

Keywords

Navigation